GlassScriptPhysician profile
Vivek Kesar
NPI 1558629857
$12,017.32
in general payments reported to CMS, 2019-2025
14 companies · $1,630 in 2025
The $1,630 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2021: $1,054 · 2022: $4,916 · 2023: $1,851 · 2024: $2,353 · 2025: $1,630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,707 · Travel and Lodging: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,706.52 |
| Travel and Lodging | $2,127.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,467.51 | 2019-2025 | Orise, Axios, Overstitch Endoscopic Suturing System |
| Olympus Corporation of The Americas | $3,191.67 | 2022-2023 | Single Use Electrosurgical Knife Kd-655, Single Use Electrosurgical Hemostatic Forceps, Disposable Distal Attachment |
| Conmed Corporation | $671.98 | 2021-2025 | Conmed Biliary, Conmed Hemostasis, Conmed Generators |
| Apollo Endosurgery US INC | $607.73 | 2021-2023 | Overstitch Endoscopic Suturing System |
| Olympus America INC. | $587.55 | 2023-2025 | Visiglide, Single Use Biliary Balloon Dilator, Single Use Aspiration Needle Na-U200h |
| Abbvie INC. | $555.60 | 2023-2025 | |
| Cook Medical LLC | $287.65 | 2021-2025 | Echotip, Echotip Insight |
| Medtronic, INC. | $235.22 | 2021-2025 | Barrx, Pillcam, Gi Genius |
| Lumendi LLC | $211.75 | 2021-2022 | |
| Steris Corporation | $67.58 | 2021 | |
| Erbe USA INC | $61.22 | 2022 | |
| Janssen Biotech, INC. | $24.46 | 2025 | Tremfya |
| Intercept Pharmaceuticals, INC. | $23.87 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.53 | 2025 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Kesar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.